openPR Logo
Press release

Finasteride Market Size by Key Players: Merck Sharp & Dohme, Sun Pharmaceuticals, Ranbaxy Laboratories, Aurobindo Pharma, Teva Pharmaceuticals, Actavis, Hetero Labs, Yabao Pharmaceuticals, Cipla, Yangtze River Pharma, Gedeon Richter, Nanjing Sanhome

Global Market Insights, Inc.

Global Market Insights, Inc.

U.S. finasteride market size may witness significant gains owing to its global dominance in alopecia treatment industry. North America generated over 2 billion revenue in alopecia market in 2015. Government approval to use finasteride in men hair loss treatment and other health problems accompanied by better results from other alternatives are influencing factors to foster regional growth.

Request for an in-depth table of contents for this report @ https://www.gminsights.com/request-toc/upcoming/732

As per American Hair Loss Association, globally approximately 750 thousand people are engaged in hair loss treatment and androgenetic alopecia accounted for more than 90% of hair loss among men in 2015. Coronary heart disease and prostate enlargement are primary reasons to cause this male pattern baldness. Moreover, prostate cancer, diabetes & obesity, and high blood pressure are other responsible factors to lead men hair loss.

Finasteride Market addresses hair loss, brought about by change in consumer eating habits, sedentary lifestyle and rise in stress levels. Blocking the male hormone testosterone and conversion into androgen dihydrotestosterone (DHT), which is responsible for hair loss is intrinsic property responsible for global finasteride market size growth.

Global alopecia (hair loss treatment) market was worth over USD 7 billion in 2015 and may surpass USD 11 billion valuation by 2024. Finasteride, being the solely oral medication approved by FDA for male hair loss treatment have an upper hand in alopecia market growth.

Major application includes treatment of benign prostatic hyperplasia (BPH), male pattern baldness, hormone replacement therapy. The product is demonstrated effective in men; it has contrary effects on female and children thus it is recommended to be not in touch with the medicine. In BPH, the prostate gland becomes larger in older men which causes problems with passing urine as it is situated near bladder.

Request for customization @ https://www.gminsights.com/roc/732

Finasteride shrinks an enlarged prostate in men which positively results in decreased urge to urinate, decreased night time urination, and less straining. The medication decreases the natural body hormone (DHT) amount in body which causes prostate growth. Effective results and no need for surgery are key reasons to drive demand in this segment.

Finasteride market share comprises of Merck Sharp & Dohme, Sun Pharmaceuticals, Ranbaxy Laboratories, Dr. Reddys Laboratories and Intas Pharmaceuticals. Other prominent companies include Aurobindo Pharma, Teva Pharmaceuticals, Actavis, Hetero Labs, Yabao Pharmaceuticals, Cipla, Yangtze River Pharma, Gedeon Richter, Nanjing Sanhome, Shandong Renhetang Hangzhou Conba Group, New Asia Pharma, and Qianjin Pharma.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Finasteride Market Size by Key Players: Merck Sharp & Dohme, Sun Pharmaceuticals, Ranbaxy Laboratories, Aurobindo Pharma, Teva Pharmaceuticals, Actavis, Hetero Labs, Yabao Pharmaceuticals, Cipla, Yangtze River Pharma, Gedeon Richter, Nanjing Sanhome here

News-ID: 1320192 • Views: 428

More Releases from Global Market Insights, Inc.

Glutathione market trends will be driven by rising beauty products demand
The rising beauty products demand influence global glutathione market size. Reports estimate that Germany oxidized glutathione market share is expected to surpass USD 7.5 million by 2025. The product is chosen as GSSG and is extensively used in the production of lotions, soaps, and creams due to its skin whitening effects. From the last few years, manufacturers have swiftly increased their production capacities as these supplements are found to be
Aroma chemicals market size is slated to grow robustly by 2026, boosted by the f …
In the latest research report compiled by Global Market Insights, Inc., aroma chemicals market size to reach USD 7.5 billion by 2026. Aroma chemicals have been become a highly sought-after compound in the production of flavorant that is used in the food and beverage industry to boost and enhance the appeal of the products. As such, demand for aroma chemicals in essential oils, fragrance oils, food, wine and spices has become
Top 3 trends accentuating Plastomer Market size until 2025
The plastomer market is expected to grow exceptionally by 2025 owing to increasing efforts on research and development by the key auto automobile players in the industry. Plastomer has found considerable application across diverse industries in products like adhesives, compounding foams, and in food and non-food packaging. The material is used to make automotive interiors like seat belts that are made of nylon or polyester, wires and cables. Driven by
Oilfield surfactants market to see 4% CAGR over 2020-2026 | Key players are Saso …
Oilfield surfactants demonstrate significant application potential in oil recovery processes, aiding in the displacement of oil near the well. This displacement can aid the production of low mobility foam, and lower interfacial tension by improving the mobility of the oil. Based on product type, the global oilfield surfactants market is broadly categorized into cationic, non-ionic, silicone, anionic, and amphoteric, which are chosen for different oil exploration activities depending on the

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business